Hopp til innhold
Close

Get alerts of updates about «CeFH lunch seminar: HbA1c in early second trimester and perinatal outcomes»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • CeFH lunch seminar: HbA1c in early second trimester and perinatal outcomes

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Event

CeFH lunch seminar: HbA1c in early second trimester and perinatal outcomes

Presentation by Ellen Øen Carlsen, Centre for Fertility and Health

Presentation by Ellen Øen Carlsen, Centre for Fertility and Health


19. Jun | 2020

11:00-12:00
Seminar
Microsoft Teams
Speaker: Ellen Øen Carlsen
Bilde av Ellen Øen Carlsen
Ellen Øen Carlsen.

Join Teams meeting

This project is part of MoBa eTox, the biobank of MoBa. Blood samples was drawn in week 18 of pregnancy for 2983 women, at the time of ultrasound, and HbA1c levels were measured. The value of measuring HbA1c at this time of pregnancy is not well-established, and currently not recommended as screening for gestational diabetes mellitus. We explored different perinatal outcomes in relation to HbA1c levels, and propose that HbA1c measurement earlier than the current recommended glucose tolerance testing in weeks 24-28 might identify women at risk of adverse outcomes.

Logo_CeFH_eng_4f_landscape.jpg

The Centre for Fertility and Health is a Centre of Excellence (SFF) at the Norwegian Institute of Public Health.